AAPL
46
-4
LYB
29
2
VFC
44
10
OI
39
-4
GE
58
-4
USB
53
-2
GRMN
46
-2
COST
44
-3
VNO
41
-9
DHI
36
-3
LOW
34
-2
CTAS
40
-2
BRK.B
47
5
ORCL
52
-3
EXPE
61
11
CMI
38
-16
FFIV
55
-3
LB
55
-2
MA
57
-3
ESS
54
-3
AAPL
46
-4
LYB
29
2
VFC
44
10
OI
39
-4
GE
58
-4
USB
53
-2
GRMN
46
-2
COST
44
-3
VNO
41
-9
DHI
36
-3
LOW
34
-2
CTAS
40
-2
BRK.B
47
5
ORCL
52
-3
EXPE
61
11
CMI
38
-16
FFIV
55
-3
LB
55
-2
MA
57
-3
ESS
54
-3
Financhill
Back

United Therapeutics 10K Form

Buy
52

UTHR
United Therapeutics

Last Price:
$307.01
Seasonality Move:
3.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q UTHR/United Therapeutics Quarterly
2023-11-01 10Q UTHR/United Therapeutics Quarterly
2023-08-02 10Q UTHR/United Therapeutics Quarterly
2023-05-03 10Q UTHR/United Therapeutics Quarterly
2022-11-02 10Q UTHR/United Therapeutics Quarterly
2022-08-03 10Q UTHR/United Therapeutics Quarterly

Receive UTHR News And Ratings

See the #1 stock for the next 7 days that we like better than UTHR

UTHR Financial Statistics

Sales & Book Value

Annual Sales: $2.9B
Cash Flow: $254.5M
Price / Cash Flow: 13.71
Annual Sales: $143.74
Price / Book: 2.13

Profitability

EPS (TTM): 24.60000
Net Income (TTM): $1.2B
Gross Margin: $2.6B
Return on Equity: 20.21%
Return on Assets: 17.14%

United Therapeutics Earnings Forecast

Key United Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 26 years for UTHR is 89.24%.
  • The Selling, General & Administrative Expenses for UTHR have been equal to 22.19% of Gross Profit Margin.
  • The Research & Development expenses have been 16.72% of Revenue.
  • The Interest Expense is 3.59% of Operating Income.
  • The Net Earning history of UTHR is 41.53% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 18 years.

United Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: UTHR
CUSIP: 91307C
Website: unither.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 5.25
Quick Ratio: 4.8

Price-to-Earnings

Trailing P/E Ratio: 12.39
Forward P/E Ratio: 10.39

UTHR Technical Analysis vs Fundamental Analysis

Buy
52
United Therapeutics (UTHR) is a Buy

Is United Therapeutics a Buy or a Sell?